FDA’s Adverse Event Reporting System Consolidation Promises Efficiency but Raises Concerns Over Data Accessibility and Potential Misuse
The U.S. Food and Drug Administration (FDA) is undertaking a significant modernization initiative by consolidating its disparate adverse event reporting…
